静脉血栓患者用利伐沙班治疗的效果

The US FDA approved expanded indications on November 2, 2012, to treat deep vein thrombosis (DVT) or pulmonary embolism (PE) and prevent recurrence of DVT and PE. So what is the effect of rivaroxaban in patients with venous thrombosis?

The therapeutic effect of rivaroxaban in the treatment of venous thrombosis:

To observe the clinical effect of rivaroxaban in the treatment of venous thrombosis.

A total of 150 patients who were recently admitted with a diagnosis of venous thrombosis were randomly divided into a control group (75 cases) and an experimental group (75 cases). The control group was treated with conventional low molecular weight heparin calcium, while the experimental group was treated with rivaroxaban tablets. Compare the coagulation function indicators before and after treatment, safety and venous thrombosis incidence rate of the two groups of patients before treatment. As a result, before treatment, there is no statistically significant difference in the coagulation function indicators between the two groups of patients (P>0.05), which is comparable.

After treatment, various coagulation indicators of the patients in the experimental group were significantly better than those in the control group, and the difference was statistically significant (P<0.001). The safety rate of patients in the experimental group was 97.33%, and the incidence rate of DVT was 1.33%. The safety rate of patients in the control group was 82.67%, and the incidence rate of DVT was 9.33%. The difference was statistically significant (P<0.05).

Conclusion: Taking rivaroxaban tablets for postoperative treatment can significantly improve the patient's coagulation function indicators, reduce surgical incision bleeding, and the incidence of subcutaneous ecchymosis and petechiae. The medication is safe and can effectively prevent the occurrence of venous thrombosis. The effect is ideal.

Rivaroxaban tablets are a drug that can be used to treat a variety of diseases. How should rivaroxaban be taken?

Rivaroxaban tablets are administered orally. Rivaroxaban 10mg can be taken with food or alone. Rivaroxaban 15 mg or 20 mg tablets should be taken with food.

When used to prevent venous thrombosis in adult patients undergoing elective hip or knee replacement surgery, the recommended dose is 10 mg orally once daily. If the wound has stopped bleeding, the first dose of medication should be between 6 and 10 hours after surgery.